* Prophase Labs Inc PRPH.OQ PRPH.O is expected to show a
fall
in quarterly revenue when it reports results on May 11.
* The New York City-based company is expected to report a
65.7% decrease in revenue to $16.3 million from $47.53 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Prophase Labs Inc
is for
a loss of 9 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prophase
Labs Inc
is $16, above its last closing price of $8.37.
This summary was machine generated May 9 at 13:52 GMT. All
figures in US dollars unless otherwise stated